86AHP may supply, &c., VAD substance to person

### 86 AHP may supply, &c., VAD substance to person > > (1)  A person’s AHP may, if authorised to do so under [subsection (2)](#GS86@Gs2@EN)  – > > > > > > (a) supply to the person a VAD substance for self-administration while the AHP is in close proximity to the person in accordance with [sections 87](#GS87@EN) and [88](#GS88@EN) ; or > > > > > > > (b) supply to the person, and assist the person to self-administer, a VAD substance; or > > > > > > > (c) administer a VAD substance to the person. > > > (2)  A person’s AHP is authorised to carry out an action for the purposes of [subsection (1)](#GS86@Gs1@EN) if – > > > > > > (a) the AHP has issued to the person under [subsection (5)](#GS86@Gs5@EN) an AHP administration certificate in relation to the person; and > > > > > > > (b) the AHP has been supplied, as the person’s PMP, the VAD substance under [section 71(1)](#GS71@Gs1@EN) or was supplied the substance under [section 74](#GS74@EN) by the person’s PMP; and > > > > > > > (c) to do so is in accordance with the statement of the person included in the person’s final permission in accordance with [section 82(3)(c)](#GS82@Gs3@Hpc@EN) or [(d)](#GS82@Gs3@Hpd@EN) ; and > > > > > > > (d) [subsection (3)](#GS86@Gs3@EN) does not apply in relation to the AHP. > > > (3)  A person’s AHP is not authorised to carry out an action for the purposes of [subsection (1)](#GS86@Gs1@EN) if – > > > > > > (a) the person has informed the AHP under [section 16(1)](#GS16@Gs1@EN) that the person no longer wishes to access voluntary assisted dying; or > > > > > > > (b) the AHP has been notified under [section 16(4)(b)](#GS16@Gs4@Hpb@EN) by the person’s PMP that the person no longer wishes to access voluntary assisted dying. > > > (4)  A person may apply to the person’s AHP for the issue of an AHP administration certificate in relation to the person. > > > (5)  A person’s AHP may issue an AHP administration certificate in relation to the person if the AHP is satisfied that it is inappropriate for the person to self-administer a VAD substance, or to self-administer the VAD substance without the AHP being in close proximity to the person or assisting the person to self-administer the VAD substance, having regard to any of the following: > > > > > > (a) the ability of the patient to self-administer the VAD substance or to self-administer the VAD substance without the AHP being in close proximity to the person or assisting the person to self-administer the VAD substance, or to digest the VAD substance; > > > > > > > (b) the patient’s concern about self-administering the VAD substance or about self-administering the VAD substance without the AHP being in close proximity to the person or assisting the person to self-administer the VAD substance; > > > > > > > (c) the method of administering the VAD substance that is suitable for the patient.